These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


408 related items for PubMed ID: 8093985

  • 1. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
    Burger LY, Martin-Iverson MT.
    Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
    [Abstract] [Full Text] [Related]

  • 2. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
    Lévesque D, Di Paolo T.
    Mol Pharmacol; 1991 May; 39(5):659-65. PubMed ID: 1674586
    [Abstract] [Full Text] [Related]

  • 3. Importance of D1 and D2 receptor stimulation for the induction and expression of cocaine-induced behavioral sensitization in preweanling rats.
    McDougall SA, Rudberg KN, Veliz A, Dhargalkar JM, Garcia AS, Romero LC, Gonzalez AE, Mohd-Yusof A, Crawford CA.
    Behav Brain Res; 2017 May 30; 326():226-236. PubMed ID: 28284952
    [Abstract] [Full Text] [Related]

  • 4. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O, Biggio G.
    Brain Res; 1990 Nov 12; 533(1):53-9. PubMed ID: 1982234
    [Abstract] [Full Text] [Related]

  • 5. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
    Morissette M, Lévesque D, Di Paolo T.
    Mol Pharmacol; 1992 Sep 12; 42(3):480-8. PubMed ID: 1357544
    [Abstract] [Full Text] [Related]

  • 6. Alterations in the dopaminergic receptor system after chronic administration of cocaine.
    Alburges ME, Narang N, Wamsley JK.
    Synapse; 1993 Aug 12; 14(4):314-23. PubMed ID: 8161369
    [Abstract] [Full Text] [Related]

  • 7. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May 12; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 8. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.
    Meller E, Bohmaker K, Goldstein M, Friedhoff AJ.
    J Pharmacol Exp Ther; 1985 Jun 12; 233(3):656-62. PubMed ID: 2861276
    [Abstract] [Full Text] [Related]

  • 9. N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain.
    Xu SX, Hatada Y, Black LE, Creese I, Sibley DR.
    J Pharmacol Exp Ther; 1991 May 12; 257(2):608-15. PubMed ID: 1674530
    [Abstract] [Full Text] [Related]

  • 10. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ.
    Neisewander JL, Ong A, McGonigle P.
    Synapse; 1995 Feb 12; 19(2):134-43. PubMed ID: 7725242
    [Abstract] [Full Text] [Related]

  • 11. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat.
    Gnanalingham KK, Hunter AJ, Jenner P, Marsden CD.
    Neuropharmacology; 1994 May 12; 33(5):647-55. PubMed ID: 7936100
    [Abstract] [Full Text] [Related]

  • 12. Chronic treatment with (-)-stepholidine alters density and turnover of D1 and D2 receptors in striatum.
    Zou LL, Cai ST, Jin GZ.
    Zhongguo Yao Li Xue Bao; 1996 Nov 12; 17(6):485-9. PubMed ID: 9863137
    [Abstract] [Full Text] [Related]

  • 13. Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
    Yu J, Coirini H, Källström L, Wiesel FA, Johnson AE.
    Synapse; 1998 Sep 12; 30(1):38-48. PubMed ID: 9704879
    [Abstract] [Full Text] [Related]

  • 14. The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats.
    Filip M, Przegaliński E.
    Pol J Pharmacol; 1997 Sep 12; 49(1):21-30. PubMed ID: 9431548
    [Abstract] [Full Text] [Related]

  • 15. Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors.
    Brown JM, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2001 Sep 12; 298(3):1150-3. PubMed ID: 11504813
    [Abstract] [Full Text] [Related]

  • 16. Dopamine D1 or D2 receptor antagonism within the basolateral amygdala differentially alters the acquisition of cocaine-cue associations necessary for cue-induced reinstatement of cocaine-seeking.
    Berglind WJ, Case JM, Parker MP, Fuchs RA, See RE.
    Neuroscience; 2006 Sep 12; 137(2):699-706. PubMed ID: 16289883
    [Abstract] [Full Text] [Related]

  • 17. Age-dependent differences in the rate of recovery of striatal dopamine D1 and D2 receptors after inactivation with EEDQ.
    Crawford CA, Rowlett JK, McDougall SA, Bardo MT.
    Eur J Pharmacol; 1994 Feb 03; 252(2):225-31. PubMed ID: 8157063
    [Abstract] [Full Text] [Related]

  • 18. Cocaine-induced sex differences in D1 receptor activation and binding levels after acute cocaine administration.
    Festa ED, Jenab S, Weiner J, Nazarian A, Niyomchai T, Russo SJ, Kemen LM, Akhavan A, Wu HB, Quinones-Jenab V.
    Brain Res Bull; 2006 Jan 15; 68(4):277-84. PubMed ID: 16377433
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens.
    Nye HE, Hope BT, Kelz MB, Iadarola M, Nestler EJ.
    J Pharmacol Exp Ther; 1995 Dec 15; 275(3):1671-80. PubMed ID: 8531143
    [Abstract] [Full Text] [Related]

  • 20. Increased occupation of D1 and D2 dopamine receptors accompanies cocaine-induced behavioral sensitization.
    Burger LY, Martin-Iverson MT.
    Brain Res; 1994 Mar 14; 639(2):228-32. PubMed ID: 8205476
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.